Targeted Atrial Inhibition of Galphaq Signaling With Inhibitory Peptides Attenuates Fibrosis and Inducibility of Atrial Fibrillation in a Canine Heart Failure Model

被引：0
|
作者：
Pfenniger, Anna
Johnson, David
Zhang, Wenwei
Ng, Justin
Swanson, Julia
Mikhailov, Aleksei
Yoo, Shin
Marszalec, William
Passman, Rod S.
Knight, Bradley P.
Arora, Rishi
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Atrial fibrillation; Gene therapy; Fibrosis; Heart Failure; Endothelial function;
D O I：
10.1161/circ.148.suppl_1.13928
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13928
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Matrix Metalloproteinase Inhibition Attenuates Atrial Remodeling and Vulnerability to Atrial Fibrillation in a Canine Model of Heart Failure
    Moe, Gordon W.
    Laurent, Gabriel
    Doumanovskaia, Liia
    Konig, Andrea
    Hu, Xudong
    Dorian, Paul
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (09) : 768 - 776
  • [2] Thyroid Hormone Replacement Therapy Attenuates Atrial Remodeling and Reduces Atrial Fibrillation Inducibility in a Rat Myocardial Infarction-Heart Failure Model
    Zhang, Youhua
    Dedkov, Eduard I.
    Lee, Bianca
    Li, Ying
    Pun, Khusbu
    Gerdes, A. Martin
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (12) : 1012 - 1019
  • [3] Edoxaban suppresses the progression of atrial fibrosis and atrial fibrillation in a canine congestive heart failure model
    Yasushi Tsujino
    Tamotsu Sakamoto
    Koshi Kinoshita
    Yosuke Nakatani
    Yoshiaki Yamaguchi
    Naoya Kataoka
    Kunihiro Nishida
    Koichiro Kinugawa
    Heart and Vessels, 2019, 34 : 1381 - 1388
  • [4] Edoxaban suppresses the progression of atrial fibrosis and atrial fibrillation in a canine congestive heart failure model
    Tsujino, Yasushi
    Sakamoto, Tamotsu
    Kinoshita, Koshi
    Nakatani, Yosuke
    Yamaguchi, Yoshiaki
    Kataoka, Naoya
    Nishida, Kunihiro
    Kinugawa, Koichiro
    HEART AND VESSELS, 2019, 34 (08) : 1381 - 1388
  • [5] Simvastatin Attenuates the Oxidative Stress, Endothelial Thrombogenicity and the Inducibility of Atrial Fibrillation in a Rat Model of Ischemic Heart Failure
    Cho, Kyoung-Im
    Koo, Sang-Ho
    Cha, Tae-Joon
    Heo, Jung-Ho
    Kim, Hyun-Su
    Jo, Gee-Bum
    Lee, Jae-Woo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (08) : 14803 - 14818
  • [6] Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation
    Knackstedt, Christian
    Gramley, Felix
    Schimpf, Thomas
    Mischke, Karl
    Zarse, Markus
    Plisiene, Jurgita
    Schmid, Michael
    Lorenzen, Johann
    Frechen, Dirk
    Neef, Philipp
    Hanrath, Peter
    Kelm, Malte
    Schauerte, Patrick
    CARDIOVASCULAR PATHOLOGY, 2008, 17 (05) : 318 - 324
  • [7] Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden?
    Burashnikov, Alexander
    Antzelevitch, Charles
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (10): : 1289 - 1297
  • [8] Chronic dantrolene treatment attenuates cardiac dysfunction and reduces atrial fibrillation inducibility in a rat myocardial infarction heart failure model
    Nofi, Colleen
    Zhang, Kuo
    Tang, Yi-Da
    Li, Ying
    Migirov, Allan
    Ojamaa, Kaie
    Gerdes, A. Martin
    Zhang, Youhua
    HEART RHYTHM O2, 2020, 1 (02): : 126 - 135
  • [9] Atrial fibrillation and biomarkers of myocardial fibrosis in heart failure
    Lofsjogard, Johan
    Persson, Hans
    Diez, Javier
    Lopez, Begona
    Gonzalez, Arantxa
    Edner, Magnus
    Mejhert, Marit
    Kahan, Thomas
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2014, 48 (05) : 299 - 303
  • [10] Atrial fibrosis heterogeneity is a risk for atrial fibrillation in pigs with ischaemic heart failure
    Zhang, Zhihao
    Vlcek, Julia
    Pauly, Valerie
    Hesse, Nora
    Bauer, Julia
    Chataut, Kavi Raj
    Maderspacher, Florian
    Volz, Lina Sophie
    Buchberger, Katharina
    Xia, Ruibing
    Hildebrand, Bianca
    Kaeaeb, Stefan
    Schuettler, Dominik
    Tomsits, Philipp
    Clauss, Sebastian
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (04)
12345